Terlipressin Market Overview:
What is Terlipressin?
Terlipressin is used as a vasoactive drug in the management of hypotension, hepatorenal syndrome and for the treatment of bleeding oesophageal varices. It is similar to vasopressin, is a prohormone of lysine?vasopressin. It is the drug of choice for the treatment of hepatorenal syndrome and mostly used for the same.
Global Terlipressin Market Outlook
The increasing occurrence of liver and kidney deceases with impaired kidney function that is hepatorenal syndrome is stimulating the growth of the terlipressin market. The prevalence of the hepatorenal syndrome is unidentified but is predicted to occur in approximately 8-10 percent of individuals. Terlipressin delivers longer biological activity and comparatively lesser side effects than vasopressin and is effective in controlling AVB. It reduces failure to control bleeding and mortality, is the first choice for pharmacological therapy when available.
The use of terlipressin as a drug has been proved to be safe, with minimal side effects that usually disappear after dose reduction, and results in an improved outcome in patients with hepatorenal syndrome. It is approved for use in Europe for patients with hepatorenal syndrome and trials to get it approved in the US are in progress. During findings, it has been found that terlipressin is studied the most for individuals with the hepatorenal syndrome and results have shown improved renal function in affected individuals than alternatives. Availability issues are restraining the growth of the terlipressin market. At present, terlipressin is not available in the United States and Canada. But is available in New Zealand, Australia, much of Europe, India & UAE and Pakistan. Easy availability of alternatives such as somatostatin, octreotide, and vapreotide restrains the growth of the market.
Global Terlipressin Market Competitive Landscape
The “Global Terlipressin Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such EVER Pharma, Hybio Pharmaceutical, Sun Pharmaceutical Industries Ltd., Shanghai Soho-Yiming Pharmaceuticals, Xi ‘an langene biological technology, SGPharma, Maya Biotech and Hangzhou Huadi Group. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
Get More Information : https://www.planetmarketreports.com/reports/global-terlipressin-market-2019-2026